Mosaic (MOS) Q2 2026 Earnings Call Transcript

Mosaic reported Q2 net loss amid sulfur affordability/availability constraints, with net sales of $2.8B (down from $3.0B) and adjusted EBITDA of $407M, pressured by sulfur-related curtailments. Management reaffirmed a liquidity-focused plan—reducing FY2026 capex to $1.2B (from $1.25B) and adding a $1B term loan—while guiding Q3 phosphate sales volumes to 1.1–1.4M tonnes at DAP prices of $820–$840/tonne and potash to 2.0–2.2M tonnes at MOP prices of $270–$290/tonne. The call also highlighted under-application risk (phosphate application forecast ~20% lower in North America and ~30% lower in Brazil), implying elevated near-term margin pressure even as DAP pricing remains firm.

Analysis

MOS is in a classic “good price / bad volume” squeeze: the market may stay supportive on paper, but the company is choosing to leave tonnes off the system to protect margins. That makes the next 1-2 quarters more about fixed-cost absorption, inventory timing, and freight than about headline fertilizer pricing; in other words, higher DAP does not fully translate into higher EBITDA when utilization is being throttled. The balance sheet actions reduce downside tail risk, but they also mean the equity is no longer a distress call option — it trades more like a cyclical earnings reset story.

The bigger second-order effect is that underapplication is compounding latent demand destruction in North and South America, which will not show up in current-quarter revenue but can create a sharper 2027-28 replenishment phase if crop prices keep firming. That favors the better-capitalized, less operationally constrained names when the cycle turns: NTR is better positioned than MOS to capture a rebound without the same sulfur bottleneck, while pure-play potash exposure like IPI has a cleaner narrative if investors rotate toward the most stable nutrient. The risk is that the current shortage thesis becomes self-defeating: if global grain prices weaken or sulfur normalizes faster than expected, the price support vanishes before MOS can restore volume.

Contrarian view: the stock may not be as obviously bearish as the P&L looks, because the market could be underestimating Q4 cash-flow improvement from working-capital release and CapEx deferral. The falsifier for a short is not a press-release slogan about supply tightness; it is a real sequential rebound in sold tonnes, lower idle costs, and evidence that the sulfur/DAP spread is converting into cash rather than just inventory mark-up. If those metrics improve, the equity can re-rate quickly because leverage risk is lower than the headline loss suggests.

Key Decisions for Investors

• Short MOS on any post-earnings bounce over the next 2-6 weeks via September/October put spreads; thesis is that near-term EBITDA revisions and fixed-cost absorption outweigh the balance-sheet relief. Falsifier: Q3 volumes/EBITDA hold better than guided and Q4 working-capital release lands early.
• Pair trade: long NTR / short MOS for 1-3 months. NTR has more diversified earnings and less exposure to sulfur-driven phosphate curtailments; the spread should work if fertilizer sentiment stays constructive but MOS remains a self-restricted volume story.
• If you want defined risk instead of outright short, buy a 1-3 month MOS put spread sized around the next earnings window. Use it as a tactical hedge against downside from lower utilization, not as a structural bankruptcy bet.
• Watchlist only, not a trade yet: if DAP remains elevated while sulfur prices normalize, MOS can re-earn its way back faster than expected. In that case, cover shorts on confirmation of sequential volume recovery and improving Q4 free cash flow.